Rheumatoid arthritis
Conditions
Interventions
Combination Therapy Group:Biqi Capsule combined with disease-modifying antirheumatic drugs
Monotherapy Group:Disease-modifying antirheumatic drugs
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1)1Aged =18 years ; (2)Meeting the 2010 ACR/EULAR classification criteria for rheumatoid arthritis
Exclusion criteria
Exclusion criteria: (1) Presence of severe infection; (2) Inability to determine the patient's status of Biqi Capsule administration; (3) Presence of severe mental disorder, cognitive impairment, or inability to comply with the study procedures; (4) Participation in other interventional trials after the index date; (5) Incomplete medical records and key data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiovascular Events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythrocyte Sedimentation Rate;C-Reactive Protein;Tender Joint Count (28 joints);Swollen Joint Count (28 joints);Morning Stiffness Duration;Disease Activity Score in 28 joints based on CRP (DAS28-CRP);Clinical Disease Activity Index;Clinical Disease Activity Index;Health Assessment Questionnaire-Disability Index ;Sharp/van der Heijde Score (assessing radiographic progression); | — |
Countries
China
Contacts
Public ContactHuang Runyue
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed